NOTTINGHAM science companies will lead a delegation of UK firms pitching for business during one of the biggest events in the American pharmaceutical industry’s calendar.

Businesses from the city account for one-third of the firms in the English delegation attending a reception during the American Association of Pharmaceutical Sciences (AAPS) annual meeting in Los Angeles.

They will meet potential customers and investors next week at an event hosted on their behalf by the British Consul in LA, Dame Barbara Hey.

The Nottingham firms taking part in the 20-strong delegation are Critical Pharmaceuticals, Design Cognition, Food and Drug Analytical Services, Molecular Profiles, Pharmaceutical Development Services and R5 Pharmaceuticals.

The US pharmaceutical market is the biggest and most lucrative in the world, with companies bidding for work in a field where the biggest firms routinely outsource research, development and service work to smaller companies.

Some of the Nottingham firms will be going to link-up with existing contacts, while others, such as specialist packaging and product development firm Design Cognition, are first- timers. Chris Penfold, the company’s chief executive, said: “We are on a fact-finding mission, to learn as much as possible about the US market and assessing where and how we can add value for US pharmaceutical companies looking to export, through our understanding of packaging requirements and regulations of global markets.”

His company is working closely with Pharmaceutical Development Services, which already has an office in the US state of South Carolina, another industry hotspot.

“Making a move into the US requires a great deal of market as well as regulatory intelligence,” said managing director Michael Gamlen.

“Close working relationships and collaboration are key to success and our respective consultancy services dovetail perfectly to add potential value for US companies.”

To read the full article, click here: http://bit.ly/Ox0hr

Watch this space for further information as I will be following up with This is Business- East Midlands (Nottingam Evening Post) after the AAPS event.

Does this apply to any of your products?  This new ruling comes into affect on the 18th November 2009 and all new products entering the market need to be compliant by November 2011. (Jane)

The European Commission has changed the labelling requirements for formulations that contain certain hair dye ingredients. Amendments to the Directive are in response to a conclusion from the Scientific Committee on Consumer Safety SCCS previously known as the SCCP – Scientific Committee on Consumer Products that said contact allergies caused by hair dyes are an increasingly important health problem. These types of reactions can cause ‘acute and severe dermatitis’ in affected individuals, according to the SCCS. In an attempt to better inform the consumer of these dangers, the Commission has altered the warnings that must be included on the labels of oxidative hair dye products and some non-oxidative products that contain strong sensitising substances. 

via Cosmetics Directive amended to flag up hair dye allergy dangers.

www.cosmeticsdesign.com

Something else to consider when designing labels. 

The European Commission is mulling labelling to help consumers’ identify animal welfare-friendly products and incentivise producers to improve welfare. But campaigners say voluntary measures are not enough. Voluntary animal welfare schemes in the EU do exist, but there is no harmonised scheme and there is confusion amongst consumers about the standards they represent. Schemes in use include organic labelling, schemes run by various animal charities like the RSCA’s Freedom Food, retailer’s schemes, and other marks like the Red Tractor, which may only refer to minimum legal requirements.

via Animal welfare labelling schemes up for discussion in Europe.

www.foodnavigator.com

Design Cognition are pleased to announce the launch of two new websites that will better meet the evolving needs of our pharmaceutical clients and the wider community in the areas of healthcare packaging design, news & compliance.

FIRSTLY, if you are involved in any way with pharmaceutical packaging design, development or managing pack change, our new healthcare-related blog site www.healthcarepackaging-pulse.com will provide you with a daily snapshot of current news & views from the world of pharmaceutical packaging & affiliated areas – from Rx through OTC, Medical Devices and GSL. Learn from the industry ‘best-in class’.

It will cover creative topics such as design, innovation, and technology,through commercial issues such as cost-optimisation and supply chain performance to regulatory and legislative change affecting the industry.

You can follow these healthcare blogs on Twitter at http://twitter.com/healthcare_pack

We hope that you enjoy them and if you are going to AAPS in Los Angeles, November 9th-12th, why not come & visit us at ‘Booth 1962′ to discuss these in more detail? See you there!

Chris Penfold

It has been mandatory to include Braille on all new EU Marketing Authorisations since 30th October 2005.

According to Article 56(a) of Council Directive 2001/83/EC it will be mandatory to include Braille on ALL EU pharmaceutical packaging by October 2010. This includes pharmaceutical products which were launched prior to October 2005.

Braille must show the name of the medicine and the appropriate strength, where more than one strength is available.

Braille alphabet

Support for Braille introduction
At Design Cognition we take the implementation of Braille very seriously. That is why our Chief Technical Officer Annie Dallison volunteered to be a member of The European Committee for Standardization (CEN) working group on Braille standards. Annie, as a leading industry expert, already had over 8 years of experience in the application of Braille on pharmaceutical packaging developing processes and establishing & setting standards for blue chip companies, making her an ideal member of the working group.

CEN working group
This CEN working group is made up of dedicated representatives from the packaging industry, trade associations, regulatory bodies and blind associations from across Europe.

This group has been working for over 3 years to determine and agree standards, including the Braille font style (Marburg medium) and measurement of Braille cell dot height that can be applied across the whole of the EU. One of the main issues for the team has been reaching agreement on the cell dot height that the blind associations feel will be sufficient to meet the needs of the blind users and also industry believe is commercially achievable. The final standard will hopefully be available before October 2010.

If you’d like find out more and how to avoid breaking the law, get your FREE ‘Introduction to Braille’ follow this link:

http://www.thepharmagateway.com/

If you are going to AAPS in Los Angeles, November 9th-12th, why not come & visit us at ‘Booth 1962′ to discuss this in more detail? See you there!

Chris Penfold